hypertension Archives - Sanford Burnham Prebys
Institute News

Sanford-Burnham wins GlaxoSmithKline drug discovery challenge

Authorpbartosch
Date

December 1, 2014

We’re excited to announce that a joint team of scientists from Sanford-Burnham at Lake Nona and Mayo Clinic has been selected as a winner of GlaxoSmithKline (GSK)’s 2014 Discovery Fast Track Challenge. The Challenge is designed to accelerate the translation of academic research into novel therapies. Researchers from the two organizations will work with partners at GSK to screen the pharmaceutical company’s library of compounds for potential new drugs to treat resistant hypertension, blood pressure that remains high despite treatment with current medications. The Challenge provides resources for small-molecule discovery and offers the opportunity for long-term collaboration. Continue reading “Sanford-Burnham wins GlaxoSmithKline drug discovery challenge”

Institute News

Sanford-Burnham’s Steven R. Smith leads clinical study on new weight-loss treatment

Authorsgammon
Date

November 3, 2014

In a new pilot study led by principal investigator Steven R. Smith, MD, the weight-loss drug lorcaserin (LOR), was tested in combination with the drug phentermine (phen) to compare safety and weight loss to administration of LOR alone. The results showed that the combination of drugs more than doubled weight loss achieved compared to LOR alone, and that treatment with LOR plus phen was not associated with any additional adverse events compared either drug alone. Continue reading “Sanford-Burnham’s Steven R. Smith leads clinical study on new weight-loss treatment”